MST for Parkinson's Disease

NAActive, not recruitingINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

September 20, 2021

Primary Completion Date

July 1, 2024

Study Completion Date

February 28, 2025

Conditions
Parkinson DiseaseDepressionMovement DisordersMajor Depressive Disorder
Interventions
DEVICE

Magnetic Seizure Theapy (MagPro XP MST)

"MST treatment will be administered over the frontal/vertex cortex using 100 Hz stimulation using the MagPro XP MST with Cool TwinCoil. The MST determination of seizure threshold will be done using 100% machine output applied at 100 Hz at progressively escalating train durations, commencing at 2 seconds and increasing by 2 seconds with each subsequent stimulation until an adequate seizure is produced. During subsequent sessions, one stimulation will be delivered using a train duration that is 4 seconds longer than the train duration at threshold (with a maximum train duration of 10 seconds).~MST treatments will be administered twice a week, for up to 16 treatments. This will be performed under the effect of anesthesia. The treatment procedure is approximately 10 minutes, followed by a recovery period of approximately 30 minutes."

Trial Locations (1)

V6T2A1

University of British Columbia, Vancouver

All Listed Sponsors
lead

University of British Columbia

OTHER